NM_005159.5(ACTC1):c.198C>G (p.Ile66Met) AND Cardiovascular phenotype

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 17, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002423800.2

Allele description [Variation Report for NM_005159.5(ACTC1):c.198C>G (p.Ile66Met)]

NM_005159.5(ACTC1):c.198C>G (p.Ile66Met)

Genes:

GJD2-DT:GJD2 divergent transcript [Gene - HGNC]
ACTC1:actin alpha cardiac muscle 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

15q14

Genomic location:

Preferred name:

NM_005159.5(ACTC1):c.198C>G (p.Ile66Met)

HGVS:

NC_000015.10:g.34793501G>C
NG_007553.1:g.7226C>G
NM_001406482.1:c.198C>G
NM_001406483.1:c.198C>G
NM_001406484.1:c.63C>G
NM_001406485.1:c.-191C>G
NM_005159.5:c.198C>GMANE SELECT
NP_001393411.1:p.Ile66Met
NP_001393412.1:p.Ile66Met
NP_001393413.1:p.Ile21Met
NP_005150.1:p.Ile66Met
NP_005150.1:p.Ile66Met
LRG_388t1:c.198C>G
LRG_388:g.7226C>G
LRG_388p1:p.Ile66Met
NC_000015.9:g.35085702G>C
NM_005159.4:c.198C>G

Protein change:

I21M

Molecular consequence:

NM_001406482.1:c.198C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406483.1:c.198C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406484.1:c.63C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_005159.5:c.198C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002718437	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jul 17, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002718437

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jul 17, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002718437.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.I66M variant (also known as c.198C>G), located in coding exon 2 of the ACTC1 gene, results from a C to G substitution at nucleotide position 198. The isoleucine at codon 66 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine